Table 2. Baseline Analytical Values in the Study Population. Results Are Presented as Mean ± SD.
| Total | Without PAD | PAD | P value | Units | |
|---|---|---|---|---|---|
| n = 63 | n = 44 | n = 19 | |||
| Glucose | 6.60 ± 2.16 | 6.44 ± 1.94 | 6.99 ± 2.66 | NS | mmol/L |
| Total cholesterol | 4.25 ± 1.24 | 4.40 ± 1.32 | 3.86 ± 0.96 | NS | mmol/L |
| LDL-cholesterol | 2.25 ± 1.01 | 2.36 ± 1.11 | 2.02 ± 0.73 | NS | mmol/L |
| HDL-cholesterol | 1.22 ± 0.34 | 1.22 ± 0.34 | 1.19 ± 0.34 | NS | mmol/L |
| Triglycerides | 1.60 ± 1.08 | 1.72 ± 1.24 | 1.34 ± 0.56 | NS | mmol/L |
| Uric acid | 368.8 ± 95.2 | 327.1 ± 83.3 | 368.8 ± 101.1 | NS | mmol/L |
| Creatinine | 88.4 ± 26.5 | 88.4 ± 26.5 | 97.24 ± 25.6 | NS | mmol/L |
| eGFR | 85 ± 34 | 85 ± 25 | 58 ± 17 | <0.01 | mL/min |
| B2M | 1.97 ± 0.86 | 1.80 ± 0.65 | 2.36 ± 1.13 | <0.05 | mg/L |
Abbreviations:eGFR, estimated glomerular filtration rate; B2M, beta 2-microglobulin; NS, non-significant